Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement
From FDA-cleared gene therapy for toddlers to blood tests predicting Alzheimer's onset, health advances are accelerating benefit plan and procurement decisions.
MarketScale Newsroom·Jul 14, 2026
